Uses of morelloflavone
作者： Wilawan Mahabusarakam , Nongporn Towatana , Kenichi Fujise
DOI:
关键词: Reductase 、 Biology 、 Morelloflavone 、 Effective dose (pharmacology) 、 In stent restenosis 、 Pharmacology
摘要: Provided herein is a method of treating postangiplasty or instent restenosis in an individual need such treatment, comprising the step administering to said effective dose morelloflavone. Also provided morelloflavone and HMG-CoA reductase inhibitor.
google.com.na 参考文章(8)
Franco Folli, Gilbert R. Gonzales, Paolo L. Manfredi, Daily dosage regimen for treating diabetes, obsity, metabolic syndrome and polycystic ovary syndrome ,(2006)
Mark Joseph Sarno, Yu Ping Li, Yu Ping Maguire, Robert L. Wolfert, Uses of lp-pla2 in combination to assess coronary risk ,(2004)
Kenichi Fujise, Zakar H. Mnjoyan, Composition and Method for Treatment and Prevention of Restenosis ,(2003)
Elizabeth Kimbleton, Jonas C. T. Wang, Jue-Chen Liu, Ying Sun, An acidified composition for topical treatment of nail and skin conditions ,(1999)
Ralph Schure, David E. Zembower, Michael T. Flavin, Geng-Xian Zhao, Yuh-Meei Lin, Biflavanoids and derivatives thereof as antiviral agents ,(1996)
Blanca Gil, M.Jesús Sanz, M.Carmen Terencio, Ramadoss Gunasegaran, Miguel Payá, M.José Alcaraz, Morelloflavone, a novel biflavonoid inhibitor of human secretory phospholipase A2 with anti-inflammatory activity☆ Biochemical Pharmacology. ,vol. 53, pp. 733- 740 ,(1997) , 10.1016/S0006-2952(96)00773-3
Walter Rozdilsky, Janet C. Onishi, James A. Milligan, Jerrold M. Liesch, Robert Giacobbe, Maria T. D. Matas, Henry Joshua, Otto D. Hensens, Sagrario M. Del Val, Michael D. Greenspan, George M. Garrity, Isabel Martin, Novel hmg-coa synthase inhibitors ,(1989)
Yu-Sheng Chao, Tian-Quan Cai, Drug combination therapy ,(2003)